A Comparative Study Of Dexmedetomidine Versus Nalbuphine For Postoperative Pain Treatment

Phase 4

• Conditions: Health Condition 1: N800- Endometriosis of uterus

• Registration Number: CTRI/2020/10/028394
• Lead Sponsor: Akbar Hasan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Female patients of age group 40 to 55 years ASA grade 1and2. Patients planned for abdominal hysterectomy under spinal anaesthesia with bupivacaine 0.5%hyperbaric. Duration of surgery around 60 to 90 minutes

Exclusion Criteria

Patients allergic to Dexmedetomidine or paracetamol. Cardiac diseases like heart block arrhythmia patients on drugs such asCCB ACE inhibitors Alfa adrenergic agonists. Pregnant patients surgery less than one hour or more than 2hours,gastric or peptic ulcer disease. Blood coagulation abnormalities. Impaired liver and kidney function patients. Hypertensive patients patients having BMI >30

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dexmedetomidine would be better rescue analgesic compared to nalbuphine in acute pain after abdominal hysterectomyTimepoint: 2months

Secondary Outcome Measures

Name	Time	Method
Dexmedetomidine may be used as rescue analgesic routinely in post operative painTimepoint: 2months